Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Federazione Diabete GiovanilefiledCriticalFederazione Diabete Giovanile
Priority to ITRM20050522priorityCriticalpatent/ITRM20050522A1/en
Publication of ITRM20050522A1publicationCriticalpatent/ITRM20050522A1/en
COMPOUNDS DERIVED FROM PIRAZIN-2-ONA; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, ATEROSCLEROSIS, HYPERTENSION, AMONG OTHERS.
STABLE, PARENTERAL PHARMACEUTICAL FORMULATION OF THE ANTIBODY AGAINST THE BETA AMYLOID PEPTIDE (ABETA); AND USE OF THE FORMULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
COMPOUNDS DERIVED FROM REPLACED BIPIRIDINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PROFILAXIS OF DISEASES SUCH AS HYPERTONIA, DIABETES, MYOCARDIAL INFARTS, BETWEEN OTHERS.
ACID DERIVATIVES 3-METHYL-2- (3- (2-PHENYL-OXAZOL-4-ILMETOXI) -CICLOHEXANOCARBONIL-AMINOBUTÍRICO AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATEROSCLEROSIS